Cancer

A new method of making cancer cells more visible to the immune system could improve how well immunotherapy works against a range of different tumors, potentially leading to more effective treatment for patients, according to […]

Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in the United States. Most patients are diagnosed at an early stage called […]

Adults who have never been married face a significantly higher risk of developing cancer than those who have been married, according to a large U.S. study of more than four million cases. The increased risk […]

A new single-cell technology is giving scientists their clearest view yet of immune cell behavior—capturing not just genetic intent, but real-time activity. By measuring RNA and proteins simultaneously, it reveals cytokine activity with greater accuracy, […]

Women’s HRT patches can treat prostate cancer just as effectively as standard hormone injections—but with fewer of the worst side effects—according to a large UK trial published in the New England Journal of Medicine. The […]

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential than researchers realized. Scientists at Scripps Research have discovered that the enzyme Pol theta (Polθ) drives […]

Researchers at NYU Abu Dhabi have developed smart molecules that can both detect and treat cancer, offering a safer and more precise approach to care. The research, published in the Journal of the American Chemical […]

Cancers that were once considered incurable now have new treatment options. Among these innovations are CAR-T (chimeric antigen receptor T cell) therapies that modify a patient’s T cells, which play an important role in immune […]

Metastases are a key problem in many types of cancer. As descendants of the primary tumor, they can grow in other organs distant from the primary site and are often difficult to identify. A research […]

Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help identify and characterize asymptomatic people with Lynch Syndrome (LS) who are more susceptible to developing cancer […]